This report describes the case of a patient with erythrodermic psoriasis who had failed all previous therapies and been hospitalized numerous times over a 12-year period that responded dramatically to treatment with infliximab. The potential utility of infliximab as a therapeutic alternative for erythrodermic psoriasis is discussed.

Erythrodermic, recalcitrant psoriasis: Clinical resolution with infliximab

Rongioletti, F.
Primo
Writing – Original Draft Preparation
;
2003-01-01

Abstract

This report describes the case of a patient with erythrodermic psoriasis who had failed all previous therapies and been hospitalized numerous times over a 12-year period that responded dramatically to treatment with infliximab. The potential utility of infliximab as a therapeutic alternative for erythrodermic psoriasis is discussed.
2003
Erythrodermic psoriasis; Etanercept; Infliximab; TNF-alpha; Antibodies, Monoclonal; Dermatitis, Exfoliative; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infliximab; Infusions, Intravenous; Middle Aged; Psoriasis; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; 2708
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/255082
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 2
social impact